Technical Name A pharmaceutical composition for treating or preventing the diseases related to proliferating activated receptor alpha (PPARα) as well as peroxisome proliferator-activated receptor gamma (PPARγ)
Project Operator I-Shou University
Summary
1.There are many studies found that metabolic syndrome and peroxisome proliferator activation receptor (Peroxisome Proliferator Activated Receptors; PPARs) gene regulation are related. The present invention relates to a combination of natural ingredients for activating PPARs, and its related products can be used in related fields such as hyperglycemia, hyperlipidemia metabolic syndrome, etc.
2.It is believed that the occurrence of colorectal cancer may be related to diet, genetic and other factors. In the era of cancer, it is important to explore the relationship between chemical protection and cancer. Nrf2 is involved in the cell's antioxidant and phase II detoxification mechanism and is called the master gene for chemical protection. The patent is a combination of natural ingredients for activating Nrf2.
Scientific Breakthrough
1.本專利乃闡述一個活化PPARs的天然物成分組合,其相關產品可用於降血糖降血脂新成代謝症候群等相關領域。
2.本發明有關一種具有化學保護活性及抗癌活性之成分組合。
本發明具有創新產品開發與明確之品牌行銷優勢,發明產品實施前後比較表如下:
1.指標或規格產銷規劃:品質較易控制。
2.功能與應用: 新功能性產品明確且品牌建構完成。
3.國內外既有水準: 創新的新功能性產品,提升新原物料產品現代化技術水準; 新分子標的評估平台,快速有效; 新品牌新氣象。
4.競爭優勢比較: 品質與安全性掌握度高,科學化功效評估,產品具有極高的市場優勢及建構地方特色品牌。
Industrial Applicability
生物技術;生醫材料與組織工程;醫藥;奈米生醫技術;美容用品 ;營養補充品
other people also saw